MedPath

KRP-104

Generic Name
KRP-104

Safety and Efficacy of Once-Daily KRP-104 in Type 2 Diabetics With Inadequate Glycemic Control on Metformin Alone

Phase 2
Completed
Conditions
Type 2 Diabetes
Interventions
Drug: Placebo
First Posted Date
2009-10-15
Last Posted Date
2014-06-26
Lead Sponsor
ActivX Biosciences, Inc.
Target Recruit Count
403
Registration Number
NCT00995345
© Copyright 2025. All Rights Reserved by MedPath